External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Retina Society 2026

We will be contributing to topics related to
-
03:44 PM
Duration 4mins Los Angeles, USA
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 2-Year Results From the Phase 3b/4 SALWEEN Trial
Colin Tan, Timothy Y. Y. Lai, Gemmy Cheung, Shih-Jen Chen, Shigeru Honda, Adrian Hock Chuan Koh, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Min Sagong, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Xiaoying Yang, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:48 PM
Duration 4mins Los Angeles, USA
Long-Term Real-World Effectiveness of Faricimab▼ in Patients With Neovascular Age-Related Macular Degeneration: 2-Year Results From the FARETINA-nAMD and FARWIDE nAMD Studies
Ali F, Borkar D, Bonine N, Ko S, Ahmed A, Amador M, Patel S, Zwick E, Toth J, Leng T, Singh R, Talks J, Varma D, Gale R, Patel P, De Salvo G, De Silva S, Chi G, Darnell A, Dodds M, Dayal P
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 PM
Duration 4mins Los Angeles, USA
Up to 7-Year Retinal Fluid Outcomes in Patients With Neovascular Age-Related Macular Degeneration treated with the Port Delivery Platform With Ranibizumab: Results from the Portal Extension Trial
Jeremy Wolfe, Gian-Andrea Thanei, Jeremy Wolfe, María Dolores Berger Lassalle, Mel Rabena, Natasha Singh, Shamika Gune, Steven Blotner
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:04 PM
Duration 4mins Los Angeles, USA
Port Delivery Platform With Ranibizumab Treatment in Eyes With Neovascular Age-Related Macular Degeneration and High Injection Burden
Yasha Modi, M Klufas, Jeffrey Moore, Robert Wirthlin, S Blotner, B Chin, A Gordon, S Gune
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:30 PM
Duration 4mins Los Angeles, USA
Visual Acuity Outcomes at Week 16 of the Phase 3 MEERKAT and SANDCAT Trials of Vamikibart in Patients With Uveitic Macular Edema
Glenn J. Jaffe, Rahul N. Khurana, Lyndell Lim, Deanna Galloway, Emma Harrell, Ivo Stilov, Zdenka Haskova, David Silverman, Laura Steeples, Eric Suhler
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:34 PM
Duration 4mins Los Angeles, USA
Vamikibart in Patients With Uveitic Macular Edema in the Phase 3 MEERKAT and SANDCAT Trials: Durability of Response 8 Weeks After the Last Per-Protocol Injection
Quan Dong Nguyen, Do B, Suhler E, Acharya N, Pavesio C, Sonoda KH, Galloway D, Haskova Z, Harrell E, Mesquida M, Silverman D, Stoilov I, Vicente A, Steeples L, Khurana R
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 PM
Duration 4mins Los Angeles, USA
Pagoda Trial Results Through Year 4: Port Delivery Platform With Ranibizumab for the Treatment of Diabetic Macular Edema
Kevin J Blinder, Lindsell L, Pieramici D, Gune S, Jones M, Liu W, Tarakegn S, Tian K
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:21 PM
Duration 3mins Los Angeles, USA
Reduction in Subretinal Hyperreflective Material Volume With Faricimab▼ vs Aflibercept 2 mg in Treatment-Naïve nAMD: A TENAYA/LUCERNE Analysis
Michael Ammar, Charles Eifrig, Jesse Jung, Nirojini Sivachandran, Isabel Bachmeier, Lei Han, Andreas Maunz, Shriji Patel, Siqing Yu, Philippe Margaron, SrinVas Sadda
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:24 PM
Duration 3mins Los Angeles, USA
Better Visual Outcomes With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve nAMD Who Had Small Lesions in TENAYA/LUCERNE
Manjot Gill, Eric Nudleman, Nicholas Dagincourt, Florie Mar, Shriji Patel, Philippe Margaron
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:37 PM
Duration 3mins Los Angeles, USA
Assessment of Intraretinal Cyst Turbidity on Optical Coherence Tomography: Clinical Implications in Eyes With DME From the YOSEMITE/RHINE Trials
Avni Patel Finn, Vas Sadda, Andreas Pollreisz, Jenny Lim, Isabel Bachmeier, Yaniv Cohen, Ali Boushehri, Manuel Amador, Alexandra Warter, Nicholas Dagincourt, Kara Gibson
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:40 PM
Duration 3mins Los Angeles, USA
Quantitative Analysis of Capillary Vessel Density, Microaneurysms, and Intraretinal Microvascular Abnormalities Following Faricimab▼ in Treatment-Naïve DME: An ALTIMETER OCT-A Post Hoc Analysis
Patricio Schlottmann, Le Boité H, Gallardo M, Eap M, Gibson K, Yang M, Patel S, Titz B, Benech A, Vazquez-Lombardi C, Couturier A
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:43 PM
Duration 3mins Los Angeles, USA
Impact of Baseline Subretinal Fluid on Treatment Outcomes in DME: Analysis of the Phase 3 YOSEMITE and RHINE Trials
Clement Chan, Medrano JR, Alabi R, Han L, Warter A, Amador M, Gibson K
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:49 PM
Duration 4mins Los Angeles, USA
Outcomes for Continuous Ranibizumab Delivery via the Port Delivery Platform in Diabetic Eyes Undergoing Vitrectomy for Vitreous Hemorrhage
Dennis Marcus, Blotner S, Bobbala A, Gune S, Lassalle D, Latkany P, Maass K
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:06 PM
Duration 4mins Los Angeles, USA
Long-Term Real-World Effectiveness of Faricimab▼ in Patients With Diabetic Macular Edema: 2-Year Results From FARETINA-DME and FARWIDE-DME Studies
Rao P, Patel S, Singh R, Bonine N, Ko S, Ahmed A, Amador M, Zwick E, Toth J, Ali F, Leng T, Borkar D, Peto T, Bailey C, Pearce I, Reynolds R, Sivaprasad S, Kiire C, Downey L, Chi G, Darnell A, Dodds M, Dayal P
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:24 PM
Duration 4mins Los Angeles, USA
Baseline Biomarker Levels in Underrepresented Patients With DME: An Exploratory Analysis of ELEVATUM
Emmanuel Chang, Christiana Dinah, Jeremiah Brown, Jennifer Lim, Adrienne Scott, Thomas Albrecht, Manuel Amador, Michael Chang, Huanxiang Lu, Alexandra Warter, Ming Yang
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon